Free tool
Healthcare stocks
We cover 52 companies in the Healthcare sector. The median market value in the group is $2.13B. Across the group, the median move over the past trading day is 0.00%. 42% of the 50 with a 200-day average trade above it. Price change over the past year runs from −76.2% to +54.9% across the middle 80 percent of the group, with a median of −12.6%.
Other lists in this group
Table
52 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% | Oct 13, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% | Oct 21, 2026 |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% | Oct 14, 2026 |
| HQY | HealthEquity, Inc. | $8.75B | Mid cap | +18.69% | Aug 27, 2026 |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% | Aug 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% | Oct 21, 2026 |
| 3391.T | Tsuruha Holdings Inc. | $6.89B | Mid cap | +5.97% | Oct 9, 2026 |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | $6.82B | Mid cap | +15.35% | Oct 23, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| MMED | MiniMed Group, Inc. | $5.48B | Mid cap | +5.41% | Sep 1, 2026 |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% | Oct 23, 2026 |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% | Aug 27, 2026 |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.26B | Mid cap | −26.59% | Oct 13, 2026 |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% | Sep 17, 2026 |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.13B | Mid cap | −28.60% | Oct 8, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $2.77B | Mid cap | +179.69% | Oct 8, 2026 |
| EMEIS.PA | emeis Société anonyme | $2.55B | Mid cap | +10.93% | Sep 23, 2026 |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +103.83% | Oct 8, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% | Oct 1, 2026 |
| NBTX | Nanobiotix S.A. | $2.26B | Mid cap | +394.99% | Sep 29, 2026 |
| MSB.AX | Mesoblast Limited | $2.25B | Mid cap | +1.03% | Aug 27, 2026 |
| MESO | Mesoblast Limited | $2.23B | Mid cap | +4.47% | Aug 27, 2026 |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% | Aug 27, 2026 |
| 302440.KS | SK bioscience Co.,Ltd. | $2.18B | Mid cap | −20.29% | Oct 26, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% | Sep 10, 2026 |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% | Sep 29, 2026 |
| OSE.PA | OSE Immunotherapeutics SA | $88.75M | Micro cap | −47.94% | Sep 28, 2026 |
| NNOX | Nano-X Imaging Ltd. | $68.83M | Micro cap | −77.77% | Sep 9, 2026 |
| CSBR | Champions Oncology, Inc. | $68.36M | Micro cap | −25.45% | Sep 14, 2026 |
| ONCO.ST | Oncopeptides AB (publ) | $68.14M | Micro cap | −67.92% | Aug 27, 2026 |
| HYFT | MindWalk Holdings Corp. | $67.19M | Micro cap | −46.04% | Sep 14, 2026 |
| LYTIX.OL | Lytix Biopharma ASA | $64.69M | Micro cap | −4.19% | Aug 27, 2026 |
| IMMP | Immutep Limited | $56.00M | Micro cap | −77.11% | Sep 2, 2026 |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $52.93M | Micro cap | −46.25% | Oct 22, 2026 |
| AIFORIA.HE | Aiforia Technologies Oyj | $49.78M | Micro cap | −60.34% | Aug 28, 2026 |
| ORX.ST | Orexo AB (publ) | $48.90M | Micro cap | −35.06% | Oct 22, 2026 |
| POCI | Precision Optics Corporation, Inc. | $47.61M | Micro cap | −12.30% | Sep 28, 2026 |
| ONCIN.OL | Oncoinvent ASA | $43.71M | Micro cap | +10.90% | Aug 27, 2026 |
| LITS | Lite Strategy, Inc. | $33.79M | Micro cap | −80.75% | Sep 28, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | $30.82M | Micro cap | −27.68% | Sep 10, 2026 |
| SVA.TO | Sernova Biotherapeutics Inc | $29.93M | Micro cap | −42.11% | Sep 10, 2026 |
| CONTX.OL | ContextVision AB (publ) | $28.31M | Micro cap | −21.11% | Aug 27, 2026 |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% | Sep 3, 2026 |
| AELIS.PA | Aelis Farma SA | $16.34M | Micro cap | −19.22% | Sep 15, 2026 |
| BLRX | BioLineRx Ltd. | $11.79M | Micro cap | −26.63% | Aug 31, 2026 |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −89.34% | Sep 28, 2026 |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% | Sep 23, 2026 |
| AVNT.TO | Avant Brands Inc. | $6.51M | Micro cap | −28.57% | Oct 15, 2026 |
| CLGN | CollPlant Biotechnologies Ltd. | $5.81M | Micro cap | −89.43% | Aug 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.